MedWatch

CHMP recommends Moderna covid-19 vaccine for approval in 12-17-year-olds

From now on, children aged between 12-17 may receive the Moderna vaccine against covid-119, according to the EU CHMP. The Danish Health Authority is taking note.

Photo: JUAN MEDINA/REUTERS / X01625

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved the use of Moderna’s covid-19 vaccine Spikevax on children aged 12-17, according to an EMA press release

The committee has approved the vaccine following studies involving 3,732 children in this age group, which showed that its efficacy and side effects much resembled those seen in adults who have received the vaccine. 

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP recommends nine new drugs, rejects one

Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.

CEO at WSA: No clarity on EQT exit plans yet

The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.

Further reading

Related articles

Trial banner

Latest news

See all jobs